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Abstract Macrophages are myeloid-derived phagocytic cells and one of the first immune cell
types to respond to microbial infections. However, a number of bacterial pathogens are resistant
to the antimicrobial activities of macrophages and can grow within these cells. Macrophages have
other immune surveillance roles including the acquisition of cytosolic components from multiple
types of cells. We hypothesized that intracellular pathogens that can replicate within macrophages
could also exploit cytosolic transfer to facilitate bacterial spread. We found that viable Francisella
tularensis, as well as Salmonella enterica bacteria transferred from infected cells to uninfected
macrophages along with other cytosolic material through a transient, contact dependent
mechanism. Bacterial transfer occurred when the host cells exchanged plasma membrane proteins
and cytosol via a trogocytosis related process leaving both donor and recipient cells intact and
viable. Trogocytosis was strongly associated with infection in mice, suggesting that direct bacterial
transfer occurs by this process in vivo.
DOI: 10.7554/eLife.10625.001
Introduction
All intracellular pathogens enter and replicate inside some type of host cell. At the earliest stage of
disease only a limited number of host cells will be infected. In order to successfully continue propa-
gation intracellular pathogens must continually infect new susceptible cells. Most of these organisms
are thought to infect a cell, replicate, re-enter the extracellular space and start the process over
again. However, re-entering the extracellular space exposes the pathogen to antibodies, comple-
ment, and other extracellular antimicrobial factors that can inhibit their growth or block their entry
into new cells. It is therefore not surprising that certain intracellular pathogens have evolved mecha-
nisms to transfer directly from infected to uninfected cells. The majority of intracellular bacterial
pathogens that are known to transfer directly from cell to cell do so through a process known as
actin based motility. While there are modest variations in the specific mechanisms employed by indi-
vidual species, in general the process is pathogen driven through the expression of effector proteins
that nucleate and polymerize host cell actin in a manner that physically propels the bacteria into a
neighboring cell (Ireton, 2013).
There are, however, natural host cell processes that transfer cytosolic material that could be
exploited by intracellular pathogens to facilitate direct cell to cell spread. Many recent studies have
demonstrated that host cells can exchange cytosolic or membrane materials with neighboring cells
through contact-dependent mechanisms (Joly and Hudrisier, 2003; Rogers and Bhattacharya,
2013). The exchange of cytosolic components occurs in different contexts across a wide range of
distinct cells types, and there are several morphologically distinct mechanisms that exchange cyto-
solic material, including nanotubes, gap junctions, cytonemes and synapses (Onfelt et al., 2006;
Rogers and Bhattacharya, 2013; Kanaporis et al., 2011; Roy et al., 2014). The different exchange
mechanism morphologies are associated with the transfer of specific types of material. For example,
gap junctions are selectively permeable to ions and small molecules while nanotubes can transfer
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functional organelles from a donor to a recipient cell (Onfelt et al., 2006; Kanaporis et al., 2011).
Certain viral pathogens are known to transfer directly from cell to cell by exploiting one or more of
these natural cellular processes. For example, human immunodeficiency virus (HIV) transfers between
cells via tunneling nanotubes (Sowinski et al., 2008), whereas Human T-lymphotophic virus (HTLV-1)
can spread directly from infected to uninfected T-cells through virological synapses (Igakura et al.,
2003).
The exchange of plasma membrane proteins between eukaryotic cells occurs through a mecha-
nism termed trogocytosis (trogo = Greek for nibble) (Joly and Hudrisier, 2003). For trogocytosis to
occur two cells form a transient intimate interaction during which the membranes appear to fuse.
The cells eventually separate, with each participant cell having acquired plasma membrane compo-
nents from the partner cell. The transferred membrane proteins retain their orientation and their
function until they are recycled via normal membrane turnover. In certain mouse tissues, over half of
the cells have undergone detectable trogocytosis at any given time (Yamanaka et al., 2009). In
immune cells, trogocytosis leads to a variety of acquired functions that likely impact infection and
immunity. For example, trogocytosis improves T cell signaling in response to antigens and dendritic
cells can activate T cells after acquiring antigens from neighboring cells (Osborne and Wetzel,
2012; Rosenits et al., 2010; Wakim and Bevan, 2011). Trogocytosis has been implicated as a criti-
cal factor in several pathologies including cancer biology, tissue engraftment, and vaccination effi-
cacy (Li et al., 2012; Chow et al., 2013; Chung et al., 2014; Zhang et al., 2008). Trogocytosis can
occur without the transfer of cytosolic material (Puaux et al., 2006), but it is unclear if the presump-
tive transient membrane fusion that occurs during certain types of cytosolic transfer also results in
trogocytosis.
eLife digest Many of the bacteria that are able to cause disease in humans and other animals
are able to grow inside their host’s cells. In doing so, these bacteria can avoid being recognized and
killed by the host’s immune system. However, the ability of the bacteria to grow within the cell is
constrained by the limited space and nutrients that are available inside the infected cell. The current
theory is that most of these bacteria eventually kill the cell they have infected and are released into
the body so that they can infect other host cells. However, since some host cells can exchange
material with their neighbors, it is also possible that the bacteria may be able to travel directly
between host cells without leaving the safety of the cell environment.
Macrophages are immune cells that patrol the body to identify and destroy damaged host cells,
bacteria and other microbes. Macrophages are also able to interact with neighboring healthy cells
through a process called trogocytosis (“trogo” is essentially Greek for nibble). During this process,
the membranes of the two participating cells briefly fuse and some of the proteins in the
membranes are transferred from one cell to the other. Afterwards, the two cells separate but retain
the membrane proteins they acquired from the other cell. The purpose of trogocytosis is poorly
understood, but it is thought to help the host to develop immune responses against microbes and
tumors.
Steele et al. investigated whether infected mouse and human cells can transfer bacteria to
healthy macrophages during trogocytosis. The experiments show that two types of bacteria – called
Francisella tularensis and Salmonella enterica – can transfer from infected cells to macrophages via
trogocytosis. Furthermore, the cells of mice infected with F. tularensis were more likely to undergo
trogocytosis, which suggests that the bacterium may promote and use this process to spread
throughout tissues in the body.
Together, Steele et al.’s finding show that some bacteria can hijack a naturally occurring cellular
process to move between host cells without re-entering the space that surrounds cells, or damaging
either the donor or recipient cell.The next steps following on from this work are to find out how
much trogocytosis contributes to the spread and progression of disease. A future goal is to
understand the molecular mechanism of trogocytosis so it may be possible to develop drugs that
can inhibit the spread of the bacteria in patients.
DOI: 10.7554/eLife.10625.002
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Although mammalian cells exchange intracellular and membrane material, there is a major gap in
our knowledge about how these transfer mechanisms impact the infectious process of intracellular
pathogens. Foreign material including beads and Mycobacterium bovis have been shown to transfer
directly between macrophages (Onfelt et al., 2006). But it is unclear how prevalent these transfer
events are, how they influence pathogenesis, and if these transfer events benefit the pathogen
(through cell to cell spread), the host (via immune detection or pathogen destruction upon transfer),
or some combination of each. These questions are important because direct cell to cell transfer via
cytosolic exchange could be a critical part of the infectious life-cycle for certain intracellular patho-
gens. For example, an estimated 60% of cells infected by HIV occur through direct viral transfer
(Iwami et al., 2015).
To investigate how cytosolic transfer affects intracellular pathogens, we used the macrophage-
tropic, facultative intracellular bacterium Francisella tularensis as a model pathogen. Importantly, F.
tularensis has not been shown to transfer between cells and lacks homologs of proteins that other
bacteria use to transfer between cells. But the rapid spread of F. tularensis to new cells and cell
types during infection suggests that direct cell to cell transfer may occur (Hall et al., 2008;
Roberts et al., 2014; Lindemann et al., 2011). Here, we demonstrate that live F. tularensis bacteria
transfer directly from infected cells to macrophages via a contact and cytosolic exchange dependent
mechanism. Direct bacterial transfer appears to occur frequently both in vitro and in a mouse infec-
tion model. Bacterial transfer was cell type specific and correlated strongly with trogocytosis, specifi-
cally the exchange of functional major histocompatibility complex I (MHC-I). Lastly, we observed
similar transfer events during infections with Salmonella enterica or fluorescent beads, suggesting
that trogocytosis-associated cell to cell transfer may be a commonly exploited phenomenon.
Results
Francisella tularensis transfers between macrophages during cytosolic
exchange
Francisella tularensis is a highly infectious zoonotic bacterial pathogen that is capable of invading
and replicating in numerous cell types including, but not limited to, epithelial cells and macrophages
(Hall et al., 2008). In a mouse model of infection the number of Francisella infected cells increases
dramatically over a short period of time (Hall et al., 2008; Roberts et al., 2014). This result sug-
gested to us that F. tularensis could spread directly from infected to uninfected cells. To test this
hypothesis we monitored GFP- F. tularensis infected J774A.1 macrophage-like (J774) cells by live
cell imaging. We found that the bacteria transferred from infected to uninfected macrophages upon
cell to cell contact (Video 1 and 2, Figure 1A). After bacterial transfer, both donor and recipient
macrophages were typically motile following separation suggesting that both cells remained viable
after bacterial transfer (Videos 1 and 2, Figure 1A). From these results, we concluded that F. tular-
ensis bacteria could transfer directly between J774 cells without entering the extracellular space.
We next developed a flow cytometry assay to quantify the transfer event to determine if the
direct transfer of bacteria from cell to cell that we observed by live cell imaging occurred at a suffi-
cient frequency to be biologically relevant. In these experiments, we infected cells with F. tularensis,
added the antibiotic gentamicin to kill extracellular bacteria and allowed the intracellular bacteria to
proliferate for 18 hr. We then added uninfected recipient cells labeled with Cell Trace Red to these
infected cells. The mixed cell population was co-cultured for 6 hr in the presence of gentamicin and
then quantified infected recipient cells by flow cytometry based on double staining for Cell Trace
Red and intracellular bacteria. Under these conditions F. tularensis transferred from infected to unin-
fected recipient J774 cells, mouse bone marrow derived macrophages (BMDMs) and primary human
monocyte derived macrophages (hMDMs) (Figure 1B).
To validate that these transfer events occurred through direct cytosolic exchange rather than
from extracellular bacteria, we tracked the transfer of F. tularensis with the cytosolic dye calcein-AM
which becomes membrane impermeable after entering the cell. F. tularensis transfer strongly corre-
lated with the transfer of the cytosolic dye between cells (Figure 1C,D). These data indicate that the
majority of newly infected cells were infected through the exchange of cytosolic material rather than
from extracellular bacteria.
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It is important to note that there are very few
extracellular F. tularensis bacteria in media con-
taining gentamicin. We found that the number of
cells infected at each tested interval was signifi-
cantly higher than the total number of extracellu-
lar bacteria in a milliliter of media (Figure 1—
figure supplement 1A). Further decreasing the
number of extracellular bacteria by inhibiting
infected cell lysis through apoptosis or necrosis
had no detectable effect on the number of cells
infected (Figure 1—figure supplement 1B).
These results further support our conclusion that
most of the newly infected macrophages become
infected via cell to cell spread.
Bacterial transfer requires cell to
cell contact
The live cell images suggested that F. tularensis
was transferred upon cell to cell contact with no
obvious infection of new cells through bacteria –
containing exosomes. We verified that cell con-
tact dependent transfer was the predominant
method for new cells to become infected in the
following experiment. We compared the amount
of cells that became infected when the cells could
come into physical contact with cells that were
physically separated by a bacteria permeable membrane. After 12 hr of co-incubation with no antibi-
otics in the media, there was a roughly 17% increase in infected cells that were able to physically
touch compared to a roughly 4% increase in infected cells that were separated by the membrane
(Figure 1E, Experimental design in Figure 1—figure supplement 2A). The reciprocal set-up yielded
similar results (data not shown). From these results, we conclude that the majority of bacterial trans-
fer events that we observed occurred from con-
tact-dependent transfer.
Viable bacteria transfer between
cells to propagate infection
F. tularensis bacteria transferred between cells,
but it is unclear if the transferred bacteria were
viable or could sustain growth in the newly
infected cells. To assess bacterial viability after
transfer, we permeabilized the host cell and mea-
sured bacterial viability by propidium iodide
exclusion. The percent of viable bacteria was sim-
ilar between the donor and recipient populations,
indicating that bacteria were not killed during
transfer between cells (Figure 2A,B and Fig-
ure 2—figure supplement 1).
The best way to accurately assess the contri-
bution of cell to cell transfer on the overall intra-
cellular proliferation of F. tularensis would be to
compare bacterial growth between conditions
that permit and inhibit cell to cell transfer. We
therefore screened numerous membrane altering
factors for an inhibitor that blocked bacterial
transfer and found that the addition of soy
Video 1. F. tularensis bacteria transfer from infected
macrophage to neighboring cells. Time lapse video of
an F. tularensis infected J774 macrophage (top middle
in opening frame) that migrates to neighboring cells,
infects those macrophages, and then migrates away. F.
tularensis is depicted in green, bright field in red. The
time is hours: minutes post inoculation. Images were
acquired every 5 min.
DOI: 10.7554/eLife.10625.003
Video 2. F. tularensis bacteria transfer from infected
macrophage to neighboring cells. Time lapse video
from an experiment separate from Video 1 depicting
an F. tularensis infected J774 macrophage migrating
toward neighboring cells, infects those macrophages,
and then migrating away. F. tularensis is depicted in
green, bright field in red. The time is hours: minutes
post inoculation. Images were acquired every 5 min.
DOI: 10.7554/eLife.10625.004
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lecithin after infecting BMDM effectively blocked the transfer of F. tularensis to uninfected cells
(Figure 2C). To test if the transferred bacteria could sustain infection, we infected approximately 1%
of a BMDM population then added soy lecithin to inhibit cell to cell contact dependent bacterial
transfer. We monitored bacterial viability over 3 days. Cells that cannot directly transfer bacteria will
lyse after peak infection (~24 hr), releasing their bacteria into antibiotic containing media. If the bac-
teria in the untreated cells survive transfer and are able to proliferate, bacterial viability should be
higher in these samples than samples treated with soy lecithin at time points after peak infection.
We found that both wild-type and transfer-inhibited cells reached peak infection at 24 hr post inocu-
lation, but the lecithin treated samples had significantly fewer viable bacteria compared to untreated
samples at 48 and 72 hr post inoculation (Figure 2D). Thus, F. tularensis exploits cell to cell transfer
to extend infection by invading and replicating in previously uninfected cells without entering the
extracellular space.
Figure 1. F. tularensis transfers between macrophages during cytosolic transfer. (A) Representative panels from live cell imaging of F. tularensis
infected J774 cells transferring bacteria. Time- hour: minutes post inoculation; * - initially infected cell; White arrow- first bacterial transfer event;
Orange arrow- second bacterial transfer event. Movie available as Video 1. (B) The proportion of recipient macrophages infected after a 6 hr co-
incubation with infected cells of the same type (3 independent experiments performed in triplicate). (C) A representative histogram of the amount of
calcein that transferred to recipient cells (log10 fluorescence) after 6 hr co-incubation. (D) The percent of infected or uninfected cells that exchanged
cytosolic content (positive for both Cell Trace Red and calcein) after 6 hr co-incubation. The uninfected population represents cells in the infected well
that did not become infected. DC refers to a doublet control (2 independent experiments performed in triplicate) (E) Bacterial transfer to uninfected
cells is significantly higher with direct cell to cell contact. Infected BMDMs on a transwell filter were suspended over uninfected BMDMs. The percent of
total cells infected on the bottom chamber (bottom) and top filter (transwell) were determined by FACS 6 and 24 hr after suspending the transwell over
uninfected cells. Side brackets indicate the change in numbers of infected cells in each chamber from 6 to 24 hr. Transfer to BMDMs separated from
the initially infected cells was significantly lower than transfer to BMDMS in contact with the infected cell population. (3 independent experiments
performed in triplicate). (Mean +/- SD). (***p<0.001)
DOI: 10.7554/eLife.10625.005
The following figure supplements are available for figure 1:
Figure supplement 1. The extracellular space is not a major source of infectious bacteria.
DOI: 10.7554/eLife.10625.006
Figure supplement 2. Experimental design and bacterial motility for transwell assay.
DOI: 10.7554/eLife.10625.007
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Bacterial transfer is cell type specific
Many bacterial species transfer from cell to cell through bacteria mediated processes, such as actin
based motility. These bacteria can spread between several different host cell types because the
transfer mechanisms are driven by bacterial effectors, (Tilney et al., 1990; Makino et al., 1986;
Heinzen et al., 1993). To address if F. tularensis transfer occurs through a host or bacterial medi-
ated process, we tested F. tularensis transfer between different host cell types. Specifically, we com-
pared bacterial transfer between TC-1 epithelial cells, bacterial transfer between macrophages, and
bacterial transfer from TC-1 epithelial cells to macrophages. Although F. tularensis replicates well in
TC-1 epithelial cells (Fuller et al., 2008), F. tularensis did not detectably transfer from infected to
uninfected TC-1 cells (Figure 3A,B). However, when we added uninfected BMDMs to the infected
TC-1 cells, the BMDMs became infected (Figure 3C). The number of infected epithelial cells did not
change when BMDMs were added, indicating that the bacteria did not transfer from BMDMs to
uninfected epithelial cells (Figure 3C). These data indicate that F. tularensis transfer is limited to spe-
cific recipient cell types and suggest that F. tularensis transfer is likely a host mediated process.
F. tularensis does not transfer via previously described bacterial
transfer mechanisms
Recipient cell type specificity suggests that F. tularensis does not use the transfer mechanisms
described in other bacterial pathogens. We further tested this conclusion by comparing F. tularensis
transfer to other known bacterial mechanisms. We found that F. tularensis did not form actin tails
that are characteristic of bacterial pathogens such as L. monocytogenes, suggesting that F. tularensis
does not use actin based motility (Figure 3—figure supplement 1A–C). Likewise, actin based motil-
ity requires continual bacterial protein synthesis (Tilney et al., 1990); but, bacterial protein synthesis
was not required for F. tularensis transfer (Figure 3—figure supplement 1D). A proposed alterna-
tive form of F. tularensis spread is through an autophagy related mechanism termed the Francisella
containing vacuole (Checroun et al., 2006; Starr et al., 2012), but inhibiting autophagy with 3-
methyladenine (3MA) or using ATG5 knockout BMDMs did not block bacterial transfer (Figure 3—
Figure 2. Live bacteria transfer to macrophages during bacterial transfer. (A) The percent of viable bacteria (propidium iodide negative) in donor and
recipient BMDMs (2 independent experiments, 50 fields of view each) (B) Micrographs of propidium idodide treated permeabilized F. tularensis
infected BMDMs. Arrow- propidium iodide positive bacterium. Scale bar- 10 uM. (C) The number of cells infected in untreated or soy lecithin treated
BMDMs. Infected BMDMs in soy lecithin treated (grey) and untreated (black) were quantified by FACS at indicated times post inoculation. Data are
presented as number of infected cells regardless of number of bacteria per infected cell. Soy lecithin was added to the treated populations after initial
infection with F. tularensis. (D) Soy lecithin does not inhibit F. tularensis intracellular replication. The number of viable bacteria in untreated or soy
lecithin treated BMDMs was quantified at indicated times by dilution plating and calculation of colony forming units. Lecithin was added at 6 hr post
inoculation (3 independent experiments performed in triplicate for both lecithin experiments). (Mean +/- SD). (ns p>0.05, *p<0.05, **p<0.01,
***p<0.001).
DOI: 10.7554/eLife.10625.008
The following figure supplement is available for figure 2:
Figure supplement 1. Propidium iodide can access and bind to dead intracellular bacteria following saponin treatment.
DOI: 10.7554/eLife.10625.009
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figure supplement 1E, data not shown). Altogether these data are consistent with F. tularensis
exploiting host-mediated cytosolic transfer for cell to cell spread.
Bacterial transfer correlates with trogocytosis
One mechanism for cytosolic exchange observed in cytotoxic T cells (CTL) occurs when pores con-
necting the cytosol form between the CTL and the target cell (Stinchcombe et al., 2001). During
this cytosolic intermingling, the cells also exchange specific plasma membrane proteins
(Stinchcombe et al., 2001). The cell to cell exchange of intact and functional plasma membrane pro-
teins that retain their orientation is termed trogocytosis (Joly and Hudrisier, 2003). We noted a sim-
ilar phenomenon of plasma membrane transfer following bacterial transfer. Newly infected recipient
BMDMs frequently acquired plasma membrane proteins as well as cytosolic material from the initially
infected cell (Figure 4A,B). Interestingly, transferred plasma membrane proteins retained their orien-
tation; so membrane proteins that were surface exposed on the initially infected cell were also sur-
face exposed on the newly infected recipient cell. In the presented images, the cells were stained
with a biotin succinimidyl ester prior to mixing the cells with differentially labelled BMDMs. The
Figure 3. Bacterial transfer is cell type specific. (A) Percentage of infected J774 macrophages or TC-1 epithelial cells at the indicated time post
inoculation (log10 fluorescence). (B) A compilation of the number of J774 or TC-1 cells infected over time. Statistics represent test for a significant
increase in the number of cells infected compared to the previous 6 hr time point. (C) TC-1 to TC-1 transfer vs TC-1 to BMDM transfer after a 0 or 18 hr
co-incubation. (All results from 3 independent experiments performed in triplicate) (Mean +/- SD). (ns p>0.05, *p<0.05, **p<0.01).
DOI: 10.7554/eLife.10625.010
The following figure supplement is available for figure 3:
Figure supplement 1. F. tularensis does not transfer via actin based motility or autophagy.
DOI: 10.7554/eLife.10625.011
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mixed population was then labeled with a fluorescent conjugated streptavidin immediately before
fixation. As a result, the protein must be surface exposed before and after transfer to be labelled
(Figure 4A,B). These data are consistent with trogocytosis and imply that trogocytosis occurs at the
same time as bacterial transfer. Importantly, these results indicate that trogocytosis can be used as a
marker for bacterial transfer and differentiate direct F. tularensis transfer from more conventional
infection mechanisms such as actin based motility or reinfection by extracellular bacteria.
To quantify how often bacterial transfer resulted in detectable levels of trogocytosis, we moni-
tored major histocompatibility complex I (MHC-I) transfer between infected donor and uninfected
recipient BMDMs (Wakim and Bevan, 2011; Smyth et al., 2008). We infected C57BL/6 (B6) BMDMs
(MHC-I H2-Kb) and added uninfected Balb/c BMDMs (MHC-I H2-Kd) to the infected B6 cells. After
6 hr of co-incubation, we assayed the Balb/c BMDMs for both F. tularensis infection and the acquisi-
tion of B6 MHC-I. We found that infection increased the amount of Balb/c BMDMs that acquired B6
MHC-I (Figure 4—figure supplement 1A). Likewise, newly infected Balb/c cells were significantly
more likely to acquire B6 MHC-I than neighboring Balb/c cells that did not become infected
(Figure 4C). As with bacterial transfer, trogocytosis did not require de novo host or bacterial protein
synthesis and was inhibited by treatment with lecithin (Figure 4—figure supplement 2). We also
observed MHC-I exchange during bacterial transfer when monitoring hMDMs (Figure 4D). The sur-
face exposed MHC-I likely remained functional after transfer because it was capable of binding the
ovalbumin derived peptide SIINFEKL (Figure 4E). Taken together, these data indicate that trogocy-
tosis occurred concurrently with bacterial transfer.
Figure 4. Plasma membrane protein transfer correlates with bacterial transfer. (A) Fluorescence micrographs of BMDMs before, during, and after
trogocytosis. (B) A donor [white plasma membrane] and trogocytosis positive recipient BMDM [red cell] exchanging cytosolic material and bacteria. The
bottom right panel is a 3D rendering of the Z-stack from the cells in the top panel. Percent of trogocytosis positive recipient cells that are (C) BMDMs
or (D) hMDMs. (E) The percent of Balb/c recipient BMDMs that acquired SIINFEKL peptide bound MHC-I from B6 BMDMs. (F) The percent of infected
splenocytes that underwent trogocytosis in a mouse infection model (8 or 9 mice per group from 4 independent experiments). DC refers to a doublet
control. (All tissue culture data are from 3–4 independent experiments performed in triplicate) (Scale bar- 10 um) (Mean +/- SD). (ns p>0.05, *p<0.05,
**p<0.01, ***p<0.001)
DOI: 10.7554/eLife.10625.012
The following figure supplements are available for figure 4:
Figure supplement 1. Plasma membrane protein exchange increases during infection.
DOI: 10.7554/eLife.10625.013
Figure supplement 2. Trogocytosis does not require de novo protein synthesis, but is inhibited by lecithin.
DOI: 10.7554/eLife.10625.014
Figure supplement 3. Trogocytosis in various cell types in mouse splenocytes.
DOI: 10.7554/eLife.10625.015
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Infected cells undergo increased levels of trogocytosis in a mouse
infection model
We found that trogocytosis is a marker for cell to cell transfer, so we assessed the exchange of
plasma membrane proteins in infected splenocytes to track bacterial transfer in vivo. We generated
chimeric mice by injecting irradiated F1 B6 and Balb/c mice with wild type Balb/c and transgenic
CD45.1+ B6 bone marrow. In these mice, no cells have genes for both CD45.1 and the MHC-I H2-
Kd. Thus, cells must undergo trogocytosis if both CD45.1 and H2-Kd are present on the surface of
an individual cell. We infected these mice with F. tularensis for 3 days and assayed their splenocytes
for infected cells and trogocytosis. Consistent with our in vitro data, F. tularensis infection increased
trogocytosis (Figure 4—figure supplement 1B). Furthermore, infected cells were significantly more
likely than uninfected splenocytes from the same mouse to possess both CD45.1 and H2-Kd
(Figure 4F). Combined with our in vitro data, these results suggest that cell to cell bacterial transfer
occurs in a mouse infection model.
The proportion of cells that underwent detectable trogocytosis varied widely between different
cell types. Of the cell types we tested, macrophages and monocytes underwent significantly more
trogocytosis than dendritic cells or a compilation of all of the other cell types (Figure 4—figure sup-
plement 3). These data further indicate that the rate of trogocytosis, and likely bacterial transfer, are
cell type specific.
Trogocytosis-associated bacterial transfer is not restricted to F.
tularensis
Recipient cell type specificity suggests that trogocytosis-associated bacterial transfer is a host medi-
ated event. If true then other bacterial species that can survive in macrophages should also exhibit
cell to cell spread by this mechanism. To test this hypothesis, we assessed bacterial transfer and tro-
gocytosis with Salmonella enterica serovar Typhimurium (S. typhimurium) infected cells. Similar to F.
tularensis cell to cell transfer, S. typhimurium infection increased trogocytosis and bacterial transfer
correlated with the exchange of MHC-I (Figure 5A, Figure 5—figure supplement 1).
We also measured the transfer of beads between BMDMs to test if trogocytosis-associated trans-
fer was specific to bacterial infections or occurred with general foreign material. Unlike infections,
beads did not increase the level of trogocytosis above baseline (Figure 5—figure supplement 1),
suggesting that a general bacterial factor increased the rate of trogocytosis and possibly bacterial
transfer. But similar to bacterial transfer, the Balb/c macrophages that acquired beads also acquired
B6 MHC-I at a significantly higher rate than macrophages that did not acquire beads (Figure 5B).
The lower rate of total trogocytosis as well as the correlation between trogocytosis and transfer is
likely due to phagocytosis of extracellular beads in the well. Taken together, our data demonstrate
trogocytosis-associated transfer of intracellular bacteria is a mechanism that potentially any macro-
phage-tropic intracellular pathogen can exploit.
Discussion
Our study demonstrates that intracellular bacteria can exploit a host cell cytosolic exchange mecha-
nism to transfer directly from infected cells to macrophages. This cytosolic exchange mechanism is
associated with trogocytosis, which is classically defined as the exchange of plasma membrane pro-
teins between two cells. Given that lecithin inhibited both plasma membrane protein and bacterial
transfer suggests that trogocytosis and cytosolic exchange are linked with respect to the mechanism
of bacterial cell to cell transfer. The bacteria are viable after transfer and can use direct cell to cell
transfer to sustain infection without entering the extracellular space. During infections, trogocytosis-
associated transfer is a likely mechanism for F. tularensis dissemination. Alveolar macrophages are
essentially the only cell type initially infected by F. tularensis following intranasal inoculation in mice
(Roberts et al., 2014). Prior to peak infection dendritic cells become infected with F. tularensis and
these newly infected cells traffic to the draining lymph node (Bar-Haim et al., 2008). We postulate
that direct cell to cell transfer is the mechanism for the bacteria to transfer from alveolar macro-
phages to these dendritic cells. Subsequent transfer events may also contribute to systemic dissemi-
nation from the lymph node.
Steele et al. eLife 2016;5:e10625. DOI: 10.7554/eLife.10625 9 of 17
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An important question is why certain bacterial species evolved mechanisms to transfer between
cells if bacteria can already transfer through cytosolic exchange. In a confluent monolayer of primary
cells, only 10–20% of macrophages became infected with F. tularensis via trogocytosis-associated
transfer in a 6 hr interval (Figure 1B). The efficiency of transfer is probably far lower in an infected
host because fewer cells are infected and the concentrations of macrophages are much lower. Bacte-
ria that encode mechanisms such as actin based motility likely increase the rate of cell to cell spread.
Additionally, certain bacterial species use actin based motility to transfer between epithelial and
endothelial cells, whereas F. tularensis does not (Makino et al., 1986; Heinzen et al., 1993;
Reed et al., 2014). It is possible these transfer mechanisms evolved so that these bacteria can trans-
fer between cells types that do not undergo trogocytosis-associated transfer or to increase the rate
of transfer.
Bacterial transfer through a trogocytosis-like process is limited to specific recipient cell types, sug-
gesting that this transfer mechanism is a host mediated event. The spread of bacteria aids in
Figure 5. Trogocytosis – associated bacterial transfer is not restricted to F. tularensis. The percent of recipient
cells that underwent plasma membrane protein transfer in response to (A) Salmonella typhimurium or (B)
fluorescent beads. The recipient BMDMs that acquired bacteria or beads grouped separately from recipient cells
in the same well that did not acquire foreign material. DC refers to a doublet control. (All results from 3–4
independent experiments performed in triplicate) (Mean +/- SD). (ns p>0.05, **p<0.01, ***p<0.001)
DOI: 10.7554/eLife.10625.016
The following figure supplement is available for figure 5:
Figure supplement 1. Plasma membrane protein exchange increases during infection.
DOI: 10.7554/eLife.10625.017
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expanding the replicative niche and possibly dissemination. So why would the host undergo a pro-
cess that is so potentially deleterious? In cancer biology, trogocytosis of pMHC-I and pMHC-II results
in a cytotoxic T cell response to the tumor (Dolan et al., 2006; Zhang et al., 2008). The immune sys-
tem may use a similar tactic during infection. Epithelial cells transfer whole antigen to macrophages
and dendritic cells to initiate a T cell response via cytosolic exchange (Ramirez and Sigal, 2002).
Trogocytosis-associated transfer may be the mechanism for this antigenic dissemination. Our work
focused on macrophages because F. tularensis primarily infects this cell type. However, macro-
phages are not an ideal cell type to stimulate an adaptive immune response. Future work on trogo-
cytosis-associated transfer in dendritic cells or in the context of adaptive immunity may reveal an
important immunological function for this process.
An unexpected observation from our work was that the rate of trogocytosis increased during
infection in primary cells and in a mouse infection model (Figure 4—figure supplement 1, Fig-
ure 5—figure supplement 1). These results suggest that infected cells expressed a signal of some
kind that initiated, enhanced, or stabilized trogocytosis. This signal is likely not soluble or generaliz-
able because the frequency of trogocytosis only increased in infected cells, not neighboring unin-
fected cells in the same experimental sample. Trogocytosis is an important immunological process
with broad consequences on host engraftment, vaccine efficacy, immune regulation and tumor rec-
ognition (Chow et al., 2013; Zhang et al., 2008; Li et al., 2012; Gu et al., 2012). Our results indi-
cate that a bacterial stimulus increases the rate of trogocytosis. Future efforts to discern the
bacterial products or processes responsible for trogocytosis up-regulation may lead to a specific
tool to manipulate trogocytosis.
Trogocytosis-associated bacterial transfer is likely beneficial to both the host and macrophage-
tropic pathogens depending on the context. Based on our results, we postulate that trogocytosis-
associated transfer benefits certain pathogens early during infection by enhancing dissemination,
but could also help initialize or propagate a T cell response that eventually clears the pathogen.
Future studies on how this process impacts pathogenesis will likely improve our understanding of
how bacteria spread in the host and how the innate immune system acquires antigen to initiate the
adaptive immune response.
Materials and methods
Bacterial growth
Francisella tularensis subsp. tularensis Schu S4 was obtained from Biodefense and Emerging Infec-
tious Research Resources Repository (BEI Resources) and Francisella tularensis subsp. holartica live
vaccine strain (LVS) expressing GFP was generated as described (Hall et al., 2008). Schu S4 was
used for all experiments shown except live cell imaging. Prior to infection, F. tularensis was grown
overnight in Chamberlin’s defined media. L. monocytogenes and S. typhimurium were grown over-
night in Luria broth.
Antibodies and critical reagents
The clone numbers for the antibodies used in these experiments: anti- F. tularensis lipopolysaccha-
ride (1.B.288, US Biologicals; Salem, MA), anti-MHC I H2-Kd (SF1-1.1.1, eBioscience; San Diego,
CA), anti-MHC I H2-Kb (AF6-88.5.5.3, eBioscience), anti-MHC I HLA-A2 (BB7.2, eBioscience), anti-
CD45.1 (A20, eBioscience), anti-CD45 (30-F11, eBioscience), anti-MHC I H2-Kb-SIINFEKL (25-D1.16,
eBioscience).
The catalog number and company for critical reagents used in these experiments: Cell Trace Red
DDAO-SE (C34553, Life Technologies; Carlsbad, CA), Calcein-AM (C3099, Life Technologies), Soy
Lecithin (Cas number 8002-43-5, Acros; Waltman, MA), phalloidin (A22287, Life Technologies), 3 um
pore Transwells (3402 Costar; Corning, NY), gentamicin (15750-060, Gibco; Carlsbad, CA)
The beads (M-1002-010, Solulink; San Diego, CA) used in these experiments were labeled with
AF488 succinimidyl ester (A-20100, Life Technologies) to make fluorescent beads.
Cell culture
TC-1 lung epithelial cells (ATCC CRL-2785; Manassas, VA) were maintained in RPMI supplemented
with sodium pyruvate, L-glutamine and non-essential amino acids in 10% fetal bovine serum (FBS,
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Gibco). J774A.1 macrophage-like cells (ATCC TIB-67) were maintained in DMEM containing 10%
FBS supplemented with sodium pyruvate and L-glutamine. All cell types were kept at 37˚C and 5%
CO2. All cell types were checked for proper morphology prior to every experiment and consistently
monitored for changes in cell replication that might indicate Mycoplasma contamination.
For the BMDM, TC-1 and J774 transfer experiments, cells were seeded the night before the
experiment at 250,000 cells per well in non-tissue culture treated 12 well dishes or 500,000 cells per
well in a 6 well dish on coverslips for microscopy. BMDMs were generated as previously described
(Mortensen et al., 2010). Unless otherwise indicated, cells were infected with F. tularensis at a mul-
tiplicity of infection (MOI) of 100 , S. typhimurium at an MOI of 10 or beads at an MOI of approxi-
mately 1. 10 ug/ml of gentamicin was added at 2 hr post inoculation when BMDMs or J774s were
infected or 3 hr post inoculation for TC-1 cells. For co-incubation experiments, the indicated recipi-
ent cell type was added to the infected cells at 18 hr post inoculation and harvested at 24 hr post
inoculation unless otherwise indicated.
Primary human monocyte derived macrophages were generated by acquiring human blood in
heparin tubes and isolating the peripheral blood mononuclear cells (PBMC) and serum on a ficoll
gradient. The cells were plated in Iscove’s modified Dulbecco’s medium (IMDM) for 2 hr. The non-
adherent cells were washed away and the media was replaced with IMDM containing 5% autologous
human serum. Primary human cells were cultured for 7 days prior to infection. The blood was iso-
lated from several healthy volunteers who gave informed, written consent following an approved
protocol by the Institutional Review Board for human volunteers at the University of North Carolina
at Chapel Hill. Blood was obtained specifically for these experiments. Different donors were used for
each experiment.
The infected cells were seeded onto a coverslip for all experiments involving primary human cells.
The coverslip was inverted in a well of uninfected cells so that the infected cells were in contact with
the uninfected cells. The reciprocal setup was used for TC-1 to BMDM transfer experiments. Other
methods to transfer the cells resulted in large amounts of cell lysis.
Live cell imaging
For live cell imaging, J774 cells were infected at an MOI of 500 with GFP-expressing F. tularensis
LVS bacteria in a synchronous infection. Briefly, the J774 cells were chilled on ice for 30 min, the
media was exchanged with media containing the bacteria, centrifuged for 5 min and then the bot-
tom of the plate was placed in a 37˚C water bath for 2 min. The cells were incubated for 15 min in
an incubator at 37˚C and 5% carbon dioxide and then the media was replaced with media containing
gentamicin. The cells were then imaged every 5 min for 24 hr using a 40x objective on an Olympus
IX70 microscope in a temperature and carbon dioxide contained chamber. All data were analyzed
using ImageJ (Schneider et al., 2012)
Bacterial transfer inhibition assay
BMDMs were seeded at 500,000 cells the night before infection. Cells were infected with an MOI of
0.5 bacteria and 10 ug/ml of gentamicin was added at 2 hr post inoculation. 0.5 mg/ml of soy leci-
thin (Acros) was added with gentamicin at 6 hr post inoculation. 50% of each sample was used for
viable bacteria quantification through serial dilutions and plating on chocolate agar. The remaining
50% of the sample was used to determine the number of cells infected as previously described.
Soy lecithin is a common emulsifier often used in food preparation that significantly blocks bacte-
rial transfer (Figure 2C) and trogocytosis (Figure 4—figure supplement 2). We were unable to
ascertain the precise mechanism behind this inhibition, but suspect that it is due to its properties as
an emulsifier because other complex phospholipid mixtures such as bovine lung surfactants (Sur-
vanta) also decreased bacterial transfer, albeit to a lesser extent (data not shown). Treating infected
cells with individual phospholipid components of soy lecithin, such as phosphatidylcholine, did not
affect bacterial transfer (data not shown).
Flow cytometry assays
When analyzing surface markers (CD45, H2-KD, H2-KB, or H2-KB-SIINFEKL), cells were stained in the
wells in which they were infected. We added 2.4G2 cell supernatant (Fc blocking buffer) to infected
cells for 5 min. The 2.4G2 supernatant was removed and antibodies were added. After 5 min, the
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cells were washed twice in PBS containing 2% fetal bovine serum (FBS), re-suspended, and fixed in
4% paraformaldehyde.
F. tularensis within infected cells were detected by permeabilizing the plasma membrane with
0.1% saponin (Millipore) in PBS and 2% FBS (Gibco). The cells were stained with an anti-F. tularensis
lipopolysaccharide antibody (US biological) conjugated to either Pacific blue, AF488, or AF647 by
combining the antibody with a succinimidyl ester of the dye. The conjugated antibody was separated
from unbound dye by a 30,000 molcular weight filter and repeated washes with PBS and glycine.
Conjugation efficiency was then assayed for each batch. We were able to detect bacteria at 1 hr
post-inoculation when as few bacteria as 1 bacteria per cell were present (data not shown).
We stained for both extracellular and intracellular bacteria and found that 1% or less of the
infected BMDMs were positive due to surface bound extracellular bacteria (data not shown). Due to
the low number of false-positive events, we did not stain specifically for extracellular bacteria in the
majority of assays so that we could minimize spectral overlap of our panel.
All mouse plasma membrane protein transfer experiments included a doublet control. Uninfected
cells from both populations were each stained with all antibodies. Each population was removed
from the plate and combined in 4% paraformaldehyde.
Transfer of cytosolic dyes
BMDMs were infected for 18 hr and then stained with calcein-AM following the manufacturer’s pro-
tocol (Invitrogen, Grand Island, NY). Uninfected BMDMs were concurrently stained with Cell Trace
Red (Invitrogen) following the manufacturer’s protocol. The different populations were either fixed
immediately for controls or combined and co-incubated for 6 hr. The cells were then stained for F.
tularensis as described above.
Transwell assay
The day before infection, BMDMs were seeded either in a 12 well plate or in the chamber of 12 mm,
3.0 uM pore transwell. Each chamber (transwell and plate) was kept separate. One chamber per pair
was infected and 10 ug/ml of gentamicin was added at 2 hr post inoculation to kill any extracellular
bacteria. At 6 hr post-inoculation, the gentamicin was removed and the infected and uninfected
chambers were combined. We then separated and harvested each chamber at either 6 or 18 hr post
inoculation.
To test for bacteria traversing the membrane, we combined the chambers, added bacteria
directly to the media of the indicated chamber (MOI 100) and tested for the number of infected cells
in each chamber 2 hr later (Figure 1—figure supplement 1B).
Extracellular bacterial enumeration
BMDMs were infected for 2 hr and then gentamicin was added. At 6 hr post inoculation, the media
was exchanged for media with or without gentamicin. At 6 hr intervals, the cells were harvested and
stained for intracellular F. tularensis and the media was serially diluted and plated on chocolate
agar. To approximate the number of cells infected every 6 hr, we used the change in infection per-
centage between intervals and assumed the number of BMDMs doubled overnight. We made this
assumption based on previous observation of chromosomal segregation in infected BMDMs by
microscopy (data not shown). The conclusions, however, would remain the same even if no cell divi-
sion is assumed.
Cell death and autophagy inhibition
BMDMs were infected and gentamicin was added at 2 hr post inoculation. At 6 hr post inoculation,
the media was exchanged for media containing gentamicin and the indicated treatment. Z-Vad
(OMe)-FMK (Cayman Chemical, Ann Arbor, MI ) was used at 20 uM and Necrostain-1 (Cayman
Chemical) at 10 uM. At 6 or 24 hr, samples were harvested and analyzed for intracellular bacteria.
Autophagy inhibition experiments were performed in the same manner, with 10 mM 3-methylade-
nine (Cayman Chemical) added at 18 hr post inoculation.
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Quantification of live and dead intracellular bacteria
Cell Trace Red BMDMs were added to GFP-expressing F. tularensis infected BMDMs 18 hr post
inoculation. At 24 hr post inoculation, the cells were treated with 0.1% saponin in PBS and 2% FBS
for 15 min at room temperature (wash buffer). 3 uM propidium iodide (PI) was added to the cell for
12 min in wash buffer. The cells were washed 3 times and then fixed in paraformaldehyde. GFP posi-
tive, PI negative live bacteria and GFP, PI double positive dead bacteria were enumerated using
fluorescence microscopy. To ensure that PI could access and bind to dead bacteria following saponin
treatment BMDMs infected with the GFP expressing intracellular growth impaired mutant
4FTT_0924 (Brunton et al., 2015) were subjected to the same procedure (Figure 2—figure supple-
ment 1).
Epithelial to BMDM transfer
TC-1 epithelial cells were infected for 6 hr as described above. A cover slip seeded with BMDMs
was inverted on top of the infected TC-1 cells and the cells were co-incubated for 18 hr in media
containing gentamicin. At 24 hr post inoculation, the slide was removed and the TC-1 and BMDM
cells that migrated from the cover slip to the bottom of the plate were stained for CD45 to deter-
mine cell type, fixed, and then stained with F. tularensis LPS antibody as described above. The 0 hr
co-incubation represents TC-1 cells that were infected for 24 hr but did not have BMDMs added to
the well.
Mice
All mice were obtained from Jackson Laboratory (Bar Harbor, ME) and were housed in specific path-
ogen free housing at the University of North Carolina- Chapel Hill. All mouse experiments were per-
formed under approved protocols from the University of North Carolina- Chapel Hill Institutional
Animal Care and Use Committee. All mice used were female. The age of mice for bone marrow mac-
rophage production varied (6 weeks to 6 months old). All mice used to generate chimeric mice were
6 weeks old at the time of irradiation or bone marrow harvest.
Bone marrow chimera mouse experiment
F1 mice from a mating of C57Bl/6 and Balb/c mice were irradiated with 1000 cGY using an X-ray irra-
diator. About 5 hr after irradiation, the irradiated mice were reconstituted by intravenous injection
of 10 million T cell depleted bone marrow cells per mouse (T cells depleted using Miltenyi CD3e
Microbead Kit following the manufacturers protocol). The bone marrow cells were approximately a
1:1 mixture of cells from wild-type Balb/c mice and CD45.1 C57bl/6 mice (B6.SJL-PTprca Pepcb/
BojJ). No blinding was performed in these studies.
Five to seven weeks after irradiation, half of the bone marrow chimera mice in each irradiation
group were infected intranasally with approximately 500 colony forming units of GFP-expressing F.
tularensis Schu S4. Mice were randomly assigned to each group. At 3 days post inoculation, the
spleens were harvested and made into a single cell suspension. The cells were treated with ammo-
nium chloride lysing buffer to removed red blood cells. The splenocytes were then stained with anti-
CD45.1 and anti-H2-KD (Balb/c MHC I) antibodies, washed, fixed in 4% paraformaldehyde, stained
for intracellular F. tularensis and analyzed by flow cytometry.
Plasma membrane protein transfer (Trogocytosis) assays
C57BL/6 BMDMs were infected and gentamicin was added at 2 hr post inoculation. At 18 hr post
inoculation, Balb/c BMDMs were added to the infected B6 cells in the presence of gentamicin. For
select experiments, 0.5 ug of the ovalbumin peptide SIINFEKL (ova 257–264) (AnaSpec Inc) was also
added at 18 hr post inoculation. At 24 hr, the cells were stained and harvested for flow cytometry.
All flow cytometry experiments included a doublet control, where stained and paraformaldehyde
fixed B6 and Balb/c cells were mixed at approximately a 1 to 1 ratio with a similar cell concentration
as the rest of the samples. The doublet control sample represents the background level of false posi-
tives for plasma membrane protein transfer due to doublets.
Experiments with S. typhimurium or magnetic beads were performed by infecting B6 BMDMs
with an MOI of 10 GFP expressing S. typhimurium bacteria or an MOI of 1 streptavidin coated mag-
netic bead (Solulink) conjugated to AF488. At 2 hr post inoculation, the cells were washed and
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media containing 25 ug/ml of gentamicin was added. At 10 hr, Balb/c BMDMs were added and the
samples were harvested at 16 hr. The samples were surface stained as previously described.
For microscopy, infected BMDMs were biotinylated at 18 hr post inoculation (Thermo Scientific;
EZ-Link Sulfo-NHS-LC-biotin following the manufacturer’s protocol). Cell Trace Red labeled BMDMs
were added to the infected cells immediately following biotinylation. 1 to 2 hr later, the samples
were stained with AF568 or PE conjugated streptavidin, fixed in 4% paraformaldehyde, and
mounted using DAPI containing mounting media. Images were acquired using the 63x objective on
a Zeiss CLSM 700 Confocal Laser Scanning Microscope. Images were acquired using Zen software
(Zeiss). All data were analyzed using ImageJ (Schneider et al., 2012). 3D images were generated
using Imaris software (Bitplane).
For human samples, HLA-A2 negative, biotinylated MDMs were added to infected HLA-A2+
MDMs at 18 hr post inoculation. The cells were co-incubated for 6 hr and then the recipient cell
population was stained with PE-streptavidin and HLA-A2 to assess plasma membrane protein
transfer.
Protein synthesis inhibition
Recipient BMDMs and the indicated treatment (0.1 ng/ml cycloheximide or 50 ug/ml chlorampheni-
col) were added to infected BMDMs at 18 hr post inoculation. The samples were assessed as
described above. At these concentrations, cycloheximide increased the basal rate of plasma mem-
brane protein transfer while chloramphenicol decreased the basal rate of plasma membrane protein
transfer.
Actin localization
Cells were infected with an MOI of 1 for L. monocytogenes or 100 for F. tularensis. Cells were har-
vested at 16 hr post inoculation, fixed, permeabilized and stained with AF647 conjugated phalloidin.
Data analysis
All statistics were performed by a 2 tailed, unpaired Student t-tests using raw data values. Confocal
microscopy experiments represent all cells from 100 total fields of view from 2 independent experi-
ments. For statistics, each field of view was treated as an independent sample. Chimeric mouse
experiments were performed with 2 mice per group in 4 independent experiments. We estimated
the size for these animal studies based on our results in tissue culture. All other experiments were
performed in triplicate for each group in at least 3 independent experiments unless otherwise
indicated.
Acknowledgements
We thank B Miller, M Braunstein, N Moorman, and A Richardson for reading the manuscript, R Bag-
nell and V Madden at the Microscopy Service Laboratory for aid with the microscopy experiments, N
Maponga at the Retrovirology Core for drawing blood, C Santos at Animal Studies Core for generat-
ing the chimeric mice and the Flow Cytometry Core. We also thank E Miao for the gift of the GFP-
expressing Salmonella typhimurium and L Lenz for GFP-expressing Listeria monocytogenes. This
work was supported by National Institutes of Health award AI082870 (TK) and by a University of
North Carolina Graduate School Dissertation Award (SS).
Additional information
Funding
Funder Grant reference number Author
National Instutes of Health
Award
AI082870 Thomas H Kawula
UNC Graduate School
Dissertation Award
Shaun Steele
Steele et al. eLife 2016;5:e10625. DOI: 10.7554/eLife.10625 15 of 17
Research article Immunology Microbiology and infectious disease
The funders had no role in study design, data collection and interpretation, or the decision to
submit the work for publication.
Author contributions
SS, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or
revising the article; LR, Acquisition of data, Analysis and interpretation of data, Drafting or revising
the article; STB, JB, Acquisition of data, Analysis and interpretation of data; THK, Conception and
design, Analysis and interpretation of data, Drafting or revising the article
Author ORCIDs
Thomas H Kawula, http://orcid.org/0000-0001-7526-5159
Ethics
Animal experimentation: This study was performed in strict accordance with the recommendations
in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of
the animals were handled according to approved institutional animal care and use committee
(IACUC) protocols (#13-213.0) of the University of North Carolina.
References
Bar-Haim E, Gat O, Markel G, Cohen H, Shafferman A, Velan B. 2008. Interrelationship between dendritic cell
trafficking and francisella tularensis dissemination following airway infection. PLoS Pathogens 4:e1000211. doi:
10.1371/journal.ppat.1000211
Brunton J, Steele S, Miller C, Lovullo E, Taft-Benz S, Kawula T. 2015. Identifying francisella tularensis genes
required for growth in host cells. Infection and Immunity 83:3015–3025. doi: 10.1128/IAI.00004-15
Checroun C, Wehrly TD, Fischer ER, Hayes SF, Celli J. 2006. Autophagy-mediated reentry of francisella tularensis
into the endocytic compartment after cytoplasmic replication. Proceedings of the National Academy of
Sciences of the United States of America 103:14578–14583. doi: 10.1073/pnas.0601838103
Chow T, Whiteley J, Li M, Rogers IM. 2013. The transfer of host MHC class i protein protects donor cells from NK
cell and macrophage-mediated rejection during hematopoietic stem cell transplantation and engraftment in
mice. Stem Cells 31:2242–2252. doi: 10.1002/stem.1458
Chung B, Stuge TB, Murad JP, Beilhack G, Andersen E, Armstrong BD, Weber JS, Lee PP. 2014. Antigen-specific
inhibition of high-avidity t cell target lysis by low-avidity t cells via trogocytosis. Cell Reports 8:871–882. doi: 10.
1016/j.celrep.2014.06.052
Dolan BP, Gibbs KD, Ostrand-Rosenberg S. 2006. Tumor-specific CD4+ t cells are activated by "cross-dressed"
dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines. The
Journal of Immunology 176:1447–1455. doi: 10.4049/jimmunol.176.3.1447
Fuller JR, Craven RR, Hall JD, Kijek TM, Taft-Benz S, Kawula TH. 2008. RipA, a cytoplasmic membrane protein
conserved among francisella species, is required for intracellular survival. Infection and Immunity 76:4934–4943.
doi: 10.1128/IAI.00475-08
Gu P, Fang Gao J, D’Souza CA, Kowalczyk A, Chou K-Y, Zhang L. 2012. Trogocytosis of CD80 and CD86 by
induced regulatory t cells. Cellular and Molecular Immunology 9:136–146. doi: 10.1038/cmi.2011.62
Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, Frelinger JA, Kawula TH. 2008. Infected-host-cell
repertoire and cellular response in the lung following inhalation of francisella tularensis schu S4, LVS, or U112.
Infection and Immunity 76:5843–5852. doi: 10.1128/IAI.01176-08
Heinzen RA, Hayes SF, Peacock MG, Hackstadt T. 1993. Directional actin polymerization associated with spotted
fever group rickettsia infection of vero cells. Infection and Immunity 61:1926–1935.
Igakura T, Stinchcombe JC, Goon PK, Taylor GP, Weber JN, Griffiths GM, Tanaka Y, Osame M, Bangham CR.
2003. Spread of HTLV-i between lymphocytes by virus-induced polarization of the cytoskeleton. Science 299:
1713–1716. doi: 10.1126/science.1080115
Ireton K. 2013. Molecular mechanisms of cell-cell spread of intracellular bacterial pathogens. Open Biology 3:
130079. doi: 10.1098/rsob.130079
Iwami S, Takeuchi JS, Nakaoka S, Mammano F, Clavel F, Inaba H, Kobayashi T, Misawa N, Aihara K, Koyanagi Y,
Sato K. 2015. Cell-to-cell infection by HIV contributes over half of virus infection. eLife 4. doi: 10.7554/eLife.
08150
Joly E, Hudrisier D. 2003. What is trogocytosis and what is its purpose? Nature Immunology 4:815. doi: 10.1038/
ni0903-815
Kanaporis G, Brink PR, Valiunas V. 2011. Gap junction permeability: selectivity for anionic and cationic probes.
AJP 300:C600–C609. doi: 10.1152/ajpcell.00316.2010
Li L, Kim S, Herndon JM, Goedegebuure P, Belt BA, Satpathy AT, Fleming TP, Hansen TH, Murphy KM,
Gillanders WE. 2012. Cross-dressed CD8 +/CD103+ dendritic cells prime CD8+ t cells following vaccination.
Proceedings of the National Academy of Sciences of the United States of America 109:12716–12721. doi: 10.
1073/pnas.1203468109
Steele et al. eLife 2016;5:e10625. DOI: 10.7554/eLife.10625 16 of 17
Research article Immunology Microbiology and infectious disease
Lindemann SR, Peng K, Long ME, Hunt JR, Apicella MA, Monack DM, Allen L-AH, Jones BD. 2011. Francisella
tularensis schu S4 o-antigen and capsule biosynthesis gene mutants induce early cell death in human
macrophages. Infection and Immunity 79:581–594. doi: 10.1128/IAI.00863-10
Makino S, Sasakawa C, Kamata K, Kurata T, Yoshikawa M. 1986. A genetic determinant required for continuous
reinfection of adjacent cells on large plasmid in s. flexneri 2a. Cell 46:551–555. doi: 10.1016/0092-8674(86)
90880-9
Mortensen BL, Fuller JR, Taft-Benz S, Kijek TM, Miller CN, Huang MTH, Kawula TH. 2010. Effects of the putative
transcriptional regulator IclR on francisella tularensis pathogenesis. Infection and Immunity 78:5022–5032. doi:
10.1128/IAI.00544-10
Onfelt B, Nedvetzki S, Benninger RKP, Purbhoo MA, Sowinski S, Hume AN, Seabra MC, Neil MAA, French PMW,
Davis DM. 2006. Structurally distinct membrane nanotubes between human macrophages support long-
distance vesicular traffic or surfing of bacteria. The Journal of Immunology 177:8476–8483. doi: 10.4049/
jimmunol.177.12.8476
Osborne DG, Wetzel SA. 2012. Trogocytosis results in sustained intracellular signaling in CD4+ t cells. The
Journal of Immunology 189:4728–4739. doi: 10.4049/jimmunol.1201507
Puaux A-L, Campanaud J, Salles A, Pre´ville X, Timmerman B, Joly E, Hudrisier D. 2006. A very rapid and simple
assay based on trogocytosis to detect and measure specific t and b cell reactivity by flow cytometry. European
Journal of Immunology 36:779–788. doi: 10.1002/eji.200535407
Ramirez MC, Sigal LJ. 2002. Macrophages and dendritic cells use the cytosolic pathway to rapidly cross-present
antigen from live, vaccinia-infected cells. The Journal of Immunology 169:6733–6742. doi: 10.4049/jimmunol.
169.12.6733
Reed SCO, Lamason RL, Risca VI, Abernathy E, Welch MD. 2014. Rickettsia actin-based motility occurs in distinct
phases mediated by different actin nucleators. Current Biology 24:98–103. doi: 10.1016/j.cub.2013.11.025
Roberts LM, Tuladhar S, Steele SP, Riebe KJ, Chen C-J, Cumming RI, Seay S, Frothingham R, Sempowski GD,
Kawula TH, Frelinger JA. 2014. Identification of early interactions between francisella and the host. Infection
and Immunity 82:2504–2510. doi: 10.1128/IAI.01654-13
Rogers RS, Bhattacharya J. 2013. When cells become organelle donors. Physiology 28:414–422. doi: 10.1152/
physiol.00032.2013
Rosenits K, Keppler SJ, Vucikuja S, Aichele P. 2010. T cells acquire cell surface determinants of APC via in vivo
trogocytosis during viral infections. European Journal of Immunology 40:3450–3457. doi: 10.1002/eji.
201040743
Roy S, Huang H, Liu S, Kornberg TB. 2014. Cytoneme-mediated contact-dependent transport of the drosophila
decapentaplegic signaling protein. Science 343:1244624. doi: 10.1126/science.1244624
Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH image to ImageJ: 25 years of image analysis. Nature
Methods 9:671–675. doi: 10.1038/nmeth.2089
Smyth LA, Harker N, Turnbull W, El-Doueik H, Klavinskis L, Kioussis D, Lombardi G, Lechler R. 2008. The relative
efficiency of acquisition of MHC:Peptide complexes and cross-presentation depends on dendritic cell type. The
Journal of Immunology 181:3212–3220. doi: 10.4049/jimmunol.181.5.3212
Sowinski S, Jolly C, Berninghausen O, Purbhoo MA, Chauveau A, Ko¨hler K, Oddos S, Eissmann P, Brodsky FM,
Hopkins C, O¨nfelt B, Sattentau Q, Davis DM. 2008. Membrane nanotubes physically connect t cells over long
distances presenting a novel route for HIV-1 transmission. Nature Cell Biology 10:211–219. doi: 10.1038/
ncb1682
Starr T, Child R, Wehrly TD, Hansen B, Hwang S, Lo´pez-Otin C, Virgin HW, Celli J. 2012. Selective subversion of
autophagy complexes facilitates completion of the brucella intracellular cycle. Cell Host & Microbe 11:33–45.
doi: 10.1016/j.chom.2011.12.002
Stinchcombe JC, Bossi G, Booth S, Griffiths GM. 2001. The immunological synapse of CTL contains a secretory
domain and membrane bridges. Immunity 15:751–761. doi: 10.1016/S1074-7613(01)00234-5
Tilney LG, Connelly PS, Portnoy DA. 1990. Actin filament nucleation by the bacterial pathogen, listeria
monocytogenes. The Journal of Cell Biology 111:2979–2988. 6 . doi: 10.1083/jcb.111.6.2979
Wakim LM, Bevan MJ. 2011. Cross-dressed dendritic cells drive memory CD8+ t-cell activation after viral
infection. Nature 471:629–632. doi: 10.1038/nature09863
Yamanaka N, Wong CJ, Gertsenstein M, Casper RF, Nagy A, Rogers IM. 2009. Bone marrow transplantation
results in human donor blood cells acquiring and displaying mouse recipient class i MHC and CD45 antigens on
their surface. PLoS ONE 4:e8489. doi: 10.1371/journal.pone.0008489
Zhang Q-J, Li X-L, Wang D, Huang X-C, Mathis JM, Duan W-M, Knight D, Shi R, Glass J, Zhang D-Q, Eisenbach
L, Jefferies WA. 2008. Trogocytosis of MHC-I/Peptide complexes derived from tumors and infected cells
enhances dendritic cell cross-priming and promotes adaptive t cell responses. PLoS ONE 3:e3097. doi: 10.
1371/journal.pone.0003097
Steele et al. eLife 2016;5:e10625. DOI: 10.7554/eLife.10625 17 of 17
Research article Immunology Microbiology and infectious disease
